NO964674D0 - Cytokinregulerende midler og fremgangsmåter for anvendelse ved patologier og tilstander forbundet med endrede cytokinnivåer - Google Patents
Cytokinregulerende midler og fremgangsmåter for anvendelse ved patologier og tilstander forbundet med endrede cytokinnivåerInfo
- Publication number
- NO964674D0 NO964674D0 NO964674A NO964674A NO964674D0 NO 964674 D0 NO964674 D0 NO 964674D0 NO 964674 A NO964674 A NO 964674A NO 964674 A NO964674 A NO 964674A NO 964674 D0 NO964674 D0 NO 964674D0
- Authority
- NO
- Norway
- Prior art keywords
- cytokine
- pathologies
- methods
- conditions associated
- regulators
- Prior art date
Links
- 102000004127 Cytokines Human genes 0.000 title 2
- 108090000695 Cytokines Proteins 0.000 title 2
- 230000007170 pathology Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/695—Corticotropin [ACTH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0802—Tripeptides with the first amino acid being neutral
- C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/400,983 US5786332A (en) | 1995-03-06 | 1995-03-06 | Cytokine restraining agents and methods of use in pathologies and conditions associated with altered cytokine levels |
US48426295A | 1995-06-07 | 1995-06-07 | |
US08/527,056 US5726156A (en) | 1995-03-06 | 1995-09-12 | Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
PCT/US1996/003112 WO1996027386A1 (en) | 1995-03-06 | 1996-03-05 | Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
Publications (2)
Publication Number | Publication Date |
---|---|
NO964674D0 true NO964674D0 (no) | 1996-11-05 |
NO964674L NO964674L (no) | 1997-01-06 |
Family
ID=27410430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO964674A NO964674L (no) | 1995-03-06 | 1996-11-05 | Cytokinregulerende midler og fremgangsmåter for anvendelse ved patologier og tilstander forbundet med endrede cytokinnivåer |
Country Status (10)
Country | Link |
---|---|
US (1) | US5726156A (no) |
EP (1) | EP0759770A4 (no) |
JP (2) | JP2810240B2 (no) |
KR (1) | KR100248030B1 (no) |
CN (1) | CN1156965A (no) |
CA (1) | CA2189250C (no) |
FI (1) | FI964449A (no) |
NO (1) | NO964674L (no) |
NZ (1) | NZ303889A (no) |
WO (1) | WO1996027386A1 (no) |
Families Citing this family (64)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5420109A (en) * | 1993-11-12 | 1995-05-30 | Houghten Pharmaceuticals, Inc. | Cytokine restraining agents |
CA2272941A1 (en) * | 1997-01-09 | 1998-07-16 | Daniela Salvemini | Attenuation of opioid tolerance by inhibiting inducible nitric oxide synthase pathways in the treatment of pain |
US8329388B2 (en) | 1997-07-30 | 2012-12-11 | Cytosorbents, Inc. | Biocompatible devices, systems, and methods for reducing levels of proinflammatory of antiinflammatory stimulators or mediators in the blood |
US20020197249A1 (en) * | 2001-04-10 | 2002-12-26 | Renal Tech International | Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood products |
US20020198487A1 (en) * | 2001-04-10 | 2002-12-26 | Renal Tech International | Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluids |
US20020197250A1 (en) * | 2001-04-10 | 2002-12-26 | Renal Tech International | Biocompatible devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood |
US20020159995A1 (en) | 1997-07-30 | 2002-10-31 | Renal Tech International | Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing |
US6242253B1 (en) | 1997-10-09 | 2001-06-05 | Regents Of The University Of California | IkB kinase, subunits thereof, and methods of using same |
AU7464998A (en) | 1997-10-27 | 1999-05-17 | Trega Biosciences, Inc. | Melanocortin receptor ligands and methods of using same |
US6673807B1 (en) * | 1998-04-06 | 2004-01-06 | Fujisawa Pharmaceutical Co., Ltd. | Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins |
AU3757999A (en) * | 1998-04-24 | 1999-11-16 | Biogen, Inc. | Adenosine a1 receptor antagonist containing composition and method for restoringdiuretic and renal function |
US6534503B1 (en) | 1998-04-28 | 2003-03-18 | Lion Bioscience Ag | Melanocortin receptor-3 ligands to treat sexual dysfunction |
EP1076649A4 (en) | 1998-04-28 | 2010-06-02 | Trega Biosciences Inc | ISOQUINOLINE-BASED COMPOUNDS IN PLACE OF MELANOCORTIN RECEPTOR LIGANDS AND METHODS OF USE |
US6284735B1 (en) | 1998-04-28 | 2001-09-04 | Lion Bioscience Ag | HP-3228 and related peptides to treat sexual dysfunction |
GB9816234D0 (en) * | 1998-07-24 | 1998-09-23 | William Harvey Research Limite | Compounds for use in the treatment of inflammation |
US6015804A (en) * | 1998-09-11 | 2000-01-18 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds to enhance interleukin-10 production |
US6716810B1 (en) * | 1998-12-09 | 2004-04-06 | Eleanor Roosevelt Institute | Composition and method for regulation of body weight and associated conditions |
US9006175B2 (en) | 1999-06-29 | 2015-04-14 | Mannkind Corporation | Potentiation of glucose elimination |
AU6605800A (en) * | 1999-07-16 | 2001-02-05 | Trega Biosciences, Inc. | Melanocortin receptor-3 ligands to treat sexual dysfunction |
PL354122A1 (en) * | 1999-08-09 | 2003-12-29 | Tripep Abtripep Ab | Pharmaceutical compositions containing tripeptides |
JP2004506417A (ja) * | 2000-07-14 | 2004-03-04 | ザイコス インク. | α−MSH関連化合物および使用方法 |
US7572436B1 (en) | 2000-09-11 | 2009-08-11 | Therapro Technologies, Inc. | Thionin as an antineoplastic and immunostimulant |
EP1322954A4 (en) * | 2000-09-13 | 2005-08-03 | Eleanor Roosevelt Inst | METHOD FOR TREATING INSULIN RESISTANCE IN OVERWEIGHT AND DIABETES |
US7488710B2 (en) | 2001-01-10 | 2009-02-10 | The United States Of America As Represented By The Department Of Health And Human Services | SFRP and peptide motifs that interact with SFRP and methods of their use |
AU2002251831A1 (en) * | 2001-01-30 | 2002-08-12 | The Regents Of The University Of Michigan | Methods for sustained release local delivery of drugs for ablation of unwanted tissue |
US20020197252A1 (en) * | 2001-04-10 | 2002-12-26 | Renal Tech International | Selective adsorption devices and systems |
US6878127B2 (en) | 2001-04-10 | 2005-04-12 | Renaltech International, Llc | Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood |
US6593455B2 (en) | 2001-08-24 | 2003-07-15 | Tripep Ab | Tripeptide amides that block viral infectivity and methods of use thereof |
EP1436317A1 (en) | 2001-09-19 | 2004-07-14 | Tripep Ab | Molecules that block viral infectivity and methods of use thereof |
ES2425392T3 (es) | 2002-03-20 | 2013-10-15 | Mannkind Corporation | Cartucho para un aparato de inhalación |
US7034004B2 (en) | 2002-05-07 | 2006-04-25 | University Of Florida | Peptides and methods for the control of obesity |
JP2007524656A (ja) * | 2003-10-23 | 2007-08-30 | セルジーン・コーポレーション | 疼痛を治療、改変および管理するための選択的サイトカイン阻害薬を含む組成物ならびにその使用方法 |
TW200518768A (en) * | 2003-11-17 | 2005-06-16 | Pepgen Corp | Methods for treatment of obesity and for promotion of weight loss |
ATE486064T1 (de) | 2004-08-20 | 2010-11-15 | Mannkind Corp | Katalyse der diketopiperazinsynthese |
PL1791542T3 (pl) | 2004-08-23 | 2015-11-30 | Mannkind Corp | Sole diketopiperazyny do dostarczania leków |
EP3556401A1 (en) | 2005-05-27 | 2019-10-23 | The University of North Carolina at Chapel Hill | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications |
AU2006290870B2 (en) | 2005-09-14 | 2013-02-28 | Mannkind Corporation | Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces |
EP2497484A3 (en) | 2006-02-22 | 2012-11-07 | MannKind Corporation | A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
DK2570147T3 (da) | 2008-06-13 | 2018-01-29 | Mannkind Corp | Tørpulverinhalator og system til lægemiddelindgivelse |
US8485180B2 (en) | 2008-06-13 | 2013-07-16 | Mannkind Corporation | Dry powder drug delivery system |
KR101628410B1 (ko) | 2008-06-20 | 2016-06-08 | 맨카인드 코포레이션 | 흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법 |
TWI532497B (zh) | 2008-08-11 | 2016-05-11 | 曼凱公司 | 超快起作用胰島素之用途 |
EP2334279A4 (en) * | 2008-10-16 | 2013-03-20 | Novan Inc | STAIN OXIDE RELEASING PARTICLES FOR MOUTH CARE APPLICATIONS |
US8314106B2 (en) | 2008-12-29 | 2012-11-20 | Mannkind Corporation | Substituted diketopiperazine analogs for use as drug delivery agents |
CA2754595C (en) | 2009-03-11 | 2017-06-27 | Mannkind Corporation | Apparatus, system and method for measuring resistance of an inhaler |
US8734845B2 (en) | 2009-06-12 | 2014-05-27 | Mannkind Corporation | Diketopiperazine microparticles with defined specific surface areas |
WO2011022652A1 (en) | 2009-08-21 | 2011-02-24 | Novan, Inc. | Topical gels |
BR112012003804B1 (pt) | 2009-08-21 | 2019-02-19 | Novan, Inc. | Curativo para ferimentos, método para formar um curativo para ferimentos, e, kit de curativo para ferimento |
US20110070269A1 (en) * | 2009-09-24 | 2011-03-24 | Therapro Technologies, Inc. | Lipopolysaccharide isolated from pyrularia tissue and/or pyrularia-associated bacteria and uses thereof |
WO2011047013A1 (en) * | 2009-10-13 | 2011-04-21 | Novan, Inc. | Nitric oxide-releasing coatings |
CA2778698A1 (en) | 2009-11-03 | 2011-05-12 | Mannkind Corporation | An apparatus and method for simulating inhalation efforts |
RU2531455C2 (ru) | 2010-06-21 | 2014-10-20 | Маннкайнд Корпорейшн | Системы и способы доставки сухих порошковых лекарств |
US8591876B2 (en) | 2010-12-15 | 2013-11-26 | Novan, Inc. | Methods of decreasing sebum production in the skin |
WO2012118829A2 (en) | 2011-02-28 | 2012-09-07 | Novan, Inc. | Tertiary s-nitrosothiol-modified nitricoxide-releasing xerogels and methods of using the same |
MY180552A (en) | 2011-04-01 | 2020-12-02 | Mannkind Corp | Blister package for pharmaceutical cartridges |
WO2012174472A1 (en) | 2011-06-17 | 2012-12-20 | Mannkind Corporation | High capacity diketopiperazine microparticles |
WO2013063160A1 (en) * | 2011-10-24 | 2013-05-02 | Mannkind Corporation | Methods and compositions for treating pain |
CA2878457C (en) | 2012-07-12 | 2021-01-19 | Mannkind Corporation | Dry powder drug delivery systems and methods |
WO2014066856A1 (en) | 2012-10-26 | 2014-05-01 | Mannkind Corporation | Inhalable influenza vaccine compositions and methods |
BR112015023168B1 (pt) | 2013-03-15 | 2021-08-10 | Mannkind Corporation | Composição de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina cristalina, método de produção de partículas de 3,6-bis(n-fumaril-4-aminobutil)-2,5-dicetopiperazina e uso de uma composição de dicetopiperazina cristalina |
CN114848614A (zh) | 2013-07-18 | 2022-08-05 | 曼金德公司 | 热稳定性干粉药物组合物和方法 |
CA2920488C (en) | 2013-08-05 | 2022-04-26 | Mannkind Corporation | Insufflation apparatus and methods |
US10307464B2 (en) | 2014-03-28 | 2019-06-04 | Mannkind Corporation | Use of ultrarapid acting insulin |
US10561806B2 (en) | 2014-10-02 | 2020-02-18 | Mannkind Corporation | Mouthpiece cover for an inhaler |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4457864A (en) * | 1981-10-23 | 1984-07-03 | University Patents, Inc. | Synthetic analogues of α-melanotropin |
US4485039A (en) * | 1982-06-11 | 1984-11-27 | University Patents, Inc. | Synthetic analogues of α-melanotropin |
US4649191A (en) * | 1984-05-10 | 1987-03-10 | Gibson-Stephens Neuropharmaceuticals, Inc. | Conformationally constrained alpha-melanotropin analogs with specific central nervous system activity |
US5028592A (en) * | 1986-08-08 | 1991-07-02 | Lipton James M | Antipyretic and anti-inflammatory peptides |
US5157023A (en) * | 1984-08-21 | 1992-10-20 | Lipton James M | Antipyretic and anti-inflammatory lys pro val compositions and method of use |
US5462927A (en) * | 1985-04-30 | 1995-10-31 | The Administrators Of The Tulane Educational Fund | Peptides aiding nerve regeneration |
ATE84420T1 (de) * | 1986-02-03 | 1993-01-15 | University Patents Inc | Verfahren zur stimulierung von melanozyten durch lokales anbringen von alpha-msh-analogen, sowie zusammensetzungen. |
ATE109793T1 (de) * | 1987-05-22 | 1994-08-15 | University Patents Inc | Lineare und zyklische analoge von alpha-msh- fragmenten mit ausserordentlicher wirkung. |
US5049547A (en) * | 1988-02-11 | 1991-09-17 | University Patents, Inc. | Composition for stimulating integumental melanocytes |
ZA908610B (en) * | 1989-11-03 | 1991-08-28 | Univ Tulane | Peptides aiding nerve regeneration |
US5408038A (en) * | 1991-10-09 | 1995-04-18 | The Scripps Research Institute | Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides |
IL101769A (en) * | 1992-05-03 | 2007-02-11 | Yeda Res & Dev | Modulation of TNF receptor action |
FR2691465B1 (fr) * | 1992-05-25 | 1995-08-11 | Pf Medicament | Complexes comprenant au moins un peptide derive de l'alpha msh, peptide, microsphere, medicament et composition galenique les comprenant. |
AU666216B2 (en) * | 1993-06-16 | 1996-02-01 | Chevron Research And Technology Company | Process for removing toxicants from aqueous petroleum waste streams |
US5420109A (en) * | 1993-11-12 | 1995-05-30 | Houghten Pharmaceuticals, Inc. | Cytokine restraining agents |
-
1995
- 1995-09-12 US US08/527,056 patent/US5726156A/en not_active Expired - Fee Related
-
1996
- 1996-03-05 EP EP96907194A patent/EP0759770A4/en not_active Withdrawn
- 1996-03-05 NZ NZ303889A patent/NZ303889A/en unknown
- 1996-03-05 KR KR1019960706227A patent/KR100248030B1/ko not_active IP Right Cessation
- 1996-03-05 WO PCT/US1996/003112 patent/WO1996027386A1/en not_active Application Discontinuation
- 1996-03-05 JP JP8527041A patent/JP2810240B2/ja not_active Expired - Fee Related
- 1996-03-05 CN CN96190451A patent/CN1156965A/zh active Pending
- 1996-03-05 CA CA002189250A patent/CA2189250C/en not_active Expired - Fee Related
- 1996-11-05 FI FI964449A patent/FI964449A/fi unknown
- 1996-11-05 NO NO964674A patent/NO964674L/no not_active Application Discontinuation
-
1998
- 1998-05-26 JP JP10144645A patent/JPH10330397A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CA2189250C (en) | 2000-08-01 |
US5726156A (en) | 1998-03-10 |
KR100248030B1 (ko) | 2000-04-01 |
EP0759770A1 (en) | 1997-03-05 |
JP2810240B2 (ja) | 1998-10-15 |
FI964449A0 (fi) | 1996-11-05 |
NZ303889A (en) | 1998-07-28 |
FI964449A (fi) | 1996-12-18 |
NO964674L (no) | 1997-01-06 |
CA2189250A1 (en) | 1996-09-12 |
JPH10330397A (ja) | 1998-12-15 |
CN1156965A (zh) | 1997-08-13 |
AU5093696A (en) | 1996-09-23 |
WO1996027386A1 (en) | 1996-09-12 |
EP0759770A4 (en) | 1998-09-23 |
JPH10509737A (ja) | 1998-09-22 |
AU703402B2 (en) | 1999-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO964674D0 (no) | Cytokinregulerende midler og fremgangsmåter for anvendelse ved patologier og tilstander forbundet med endrede cytokinnivåer | |
NO972125L (no) | Hemorroideblandinger og fremgangsmåte for anvendelse | |
NO2008002I1 (no) | Protiokonazol og salter derav | |
IS4481A (is) | Díhýdrópyramídín og notkun þeirra | |
NO951900D0 (no) | Stilkskrue og bakre spinalinstrumentering | |
EP0853465A4 (en) | ENDOVASCULAR AUXILIARY DEVICE AND APPLICATION METHOD | |
NO963858L (no) | Rörleggingsfartöy og fremgangsmåte | |
EP0726748A4 (en) | WRIST SUPPORT WITH SUPPORT ELEMENT | |
DK0713080T3 (da) | Fremgangsmåde og anordning til måling med "sing-around"-teknik | |
DK0804078T3 (da) | Sammensætning og anvendelse deraf | |
SG49579A1 (en) | Intermediate thickness and multiple furnace process line with slab storage and slab sequencing | |
DK0844875T3 (da) | Anvendelse af L-carnitin og acylderivater til nedsættelse af ceramidniveauer | |
NO963723L (no) | Flytepunktnedsettende tilsetningsstoffer og deres anvendelse | |
HU9402209D0 (en) | Device for consumption test and of permission gas-consumers | |
IL114074A0 (en) | Universal beehive support and beehive construction | |
EP0701149A3 (en) | Refraction device with polarization dependency and manufacturing method thereof | |
NO965507D0 (no) | Forbedrede fremgangsmåter for bestemmelse og justering av daglige prolaktinrytmer | |
FR2734465B3 (fr) | Oreiller de durete et profil reglables | |
NO950924D0 (no) | Rammemadrass med avtagbart madrasstrekk og vendbar hovedmadrass | |
GB9402155D0 (en) | Support member and method of use | |
NO954530D0 (no) | Aryloksycykloalkenyl- og aryloksyimino-cykloalkenylhydroksyurinstoffer | |
BR7200979U (pt) | Rocadeira manual regulavel e desmontavel | |
KR960005978U (ko) | 거울과 라이타가 내장된 시계 | |
KR960030057U (ko) | 낚시받침대에 있어서 받침구와 조립구조의 결합구조 | |
NO943517D0 (no) | Prefabrikasjonsmetode med tiltbar og flyttbar oppspenningsflate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |